Ceritinib (Zykadia) - Oncology Nurse Advisor
Skip to navigation Skip to main content

Ceritinib (Zykadia)

Slideshow

  • Slide

  • Slide

  • Slide

  • You can skip this ad in 3 seconds.

  • Slide

  • Slide

  • Slide

  • You can skip this ad in 3 seconds.

  • Slide

  • Slide

  • Slide

  • You can skip this ad in 3 seconds.

  • Slide

  • Slide

  • Slide

  • You can skip this ad in 3 seconds.

  • Slide

  • Slide

  • Slide

  • You can skip this ad in 3 seconds.

  • Slide

  • Slide

  • Slide

  • You can skip this ad in 3 seconds.

  • Slide

  • Slide

  • Slide

  • You can skip this ad in 3 seconds.

  • Slide

  • Slide

  • Slide

  • You can skip this ad in 3 seconds.

  • Slide

  • Slide

  • Slide

  • You can skip this ad in 3 seconds.

  • Slide

  • Slide

  • Slide

  • You can skip this ad in 3 seconds.

  • Slide

  • Slide

This slideshow reviews ceritinib (Zykadia), indicated for metastatic non-small cell lung cancer (NSCLC) in patients with ALK-positive tumors.

Table of Contents

Slide 4: Dosage and Administration
Slide 15: Cautions, Effects, and Interactions
Slide 23: What to Tell Your Patient
Slide 32: Reference 

 

Topics:

Drug Information Slideshows Stat Consult
  • Loading...
    Loading...
    Loading...
Next hm-slideshow in Slides